Page 2 - Michael Diem News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dr. Michael Diem Steps Down from Board of DirectorsMALVERN, Pa.--(BUSINESS WIRE)--Venatorx Pharmaceuticals, a private, clinical-stage pharmaceutical company focused on improving health outcomes for patients with difficult-to-treat drug resistant gram-negative bacterial infections and viral infections, today announce...

Bloomsbury Genetic Therapies launches with Seed financing of £5 million to develop potentially curative gene therapy treatments for rare neurological and metabolic diseasesLondon, UK, 7 October 2022 – Bloomsbury Genetic Therapies Limited (“Bloomsbury”), a  biotechnology company developin...